Rapport Therapeutics Inc. Common Stock
RAPP | NASDAQ
$38.46
-$1.20 (-3.03%)
Sep 22, 2026, 11:40 AM ET · Market open
Market Data
Market Cap $1.9B
Enterprise Value $1.47B
Beta 1.03
Average Volume 340.07K
Shares Outstanding (Diluted) 47.47M
Shares Change YoY 33.94%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US75383L1026
Price Performance
Price Change 1M -17.6%
Price Change 3M 2.0%
Price Change 6M 37.3%
Price Change YTD 41.1%
Price Change 1Y 51.9%
Price Change 3Y 90.7%
Price Change 5Y 90.7%
1M CAGR (ann.) -12.8%
1Y CAGR (ann.) 45.0%
5Y CAGR (ann.) N/A
All-Time CAGR 32.5%
Valuation
PE Ratio -13.05
Forward PE N/A
PEG Ratio 0.60
Forward PEG -0.59
PS Ratio 94.84
Forward PS N/A
PB Ratio 4.48
P/FCF Ratio -17.20
P/Adj. FCF Ratio -13.37
P/OCF Ratio -19.44
EV/Sales 73.54
EV/EBIT -9.85
EV/EBITDA -9.93
EV/FCF -13.34
Earnings Yield -7.7%
FCF Yield -5.8%
Adj. FCF Yield -7.5%
Financial Health
Net Cash $436.08M
Total Debt $10.11M
Cash & Short-Term Investments $436.08M
Total Assets $458.98M
Current Ratio 15.72
Quick Ratio 15.72
Debt / Equity Ratio 0.02
Debt / EBITDA -0.07
Debt / FCF -0.09
OCF / Debt -10.86
Interest Coverage 0.00
Altman Z-Score 30.68
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 100.0%
Operating Profit Margin -767.6%
EBITDA Margin -740.7%
Net Profit Margin -685.8%
FCF Margin -551.5%
Adj. FCF Margin -709.3%
SBC / Revenue 123.0%
SBC Impact (per share) -28.6%
Returns
Return on Assets -29.9%
Return on Equity -29.0%
Return on Invested Capital -35.5%
Return on Capital Employed -35.7%
Return on Tangible Assets -29.9%
Historical Growth (CAGR)
Revenue CAGR 3Y 150.0%
Revenue CAGR 5Y N/A
Revenue CAGR 10Y N/A
EPS CAGR 3Y -54.9%
EPS CAGR 5Y N/A
EPS CAGR 10Y N/A
FCF CAGR 3Y -35.6%
FCF CAGR 5Y N/A
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 5
EPS Growth Next 3Y -28.7%
Revenue Growth Next 3Y -50.0%
Earnings Date Nov 4, 2026
EPS Estimate (next Q) -$1.21
EPS Growth Est (next Q) 70.4%
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $64.80
Price Target Upside 63.4%
Cash Flow
Operating Cash Flow $-109.74M
Free Cash Flow $-110.3M
Adj. Free Cash Flow $-141.85M
FCF Per Share -$2.05
OCF Per Share -$2.04
OCF/S Ratio -483.4%
Income Statement
Revenue $20M
Gross Profit $20M
Operating Income $-153.52M
EBITDA $-148.14M
Net Income $-137.16M
EPS (Diluted) -$3.04
Revenue / Employee $238.1K
Profit / Employee $-1.63M
Employees 84
Add to Watchlist
Select watchlists to add or remove RAPP